Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis

Zenas Z N Yiu; L.S. Exton; Zarif K. Jabbar‐Lopez; M.F. Mohd Mustapa; Eleanor Samarasekera; A. David Burden; Ruth Murphy; Caroline Owen; Richard Parslew; Vanessa Venning; Darren M. Ashcroft; Christopher Em Griffiths; Catherine Smith; Richard B. Warren

doi:10.1016/j.jid.2016.03.035

Related publications

Article2016

Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials

Watcharee Rungapiromnan, Zenas Z N Yiu, Richard B. Warren, Christopher Em Griffiths, Darren M. Ashcroft

Article2017

001 Risk of serious infection associated with biologic therapies in psoriasis: A prospective cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Zenas Z N Yiu, Catherine Smith, A.D. Ormerod, Darren M. Ashcroft, Mark Lunt, Shernaz Walton, Rachel Murphy, Nick J. Reynolds, Christopher Em Griffiths, Richard B. Warren

Article2007

Effects of biologic therapies on the severity of skin symptoms and quality of life in patients with plaque-type psoriasis: a meta-analysis.

Kristian Reich, Rodney Sinclair, G. Evan Roberts, Christopher Em Griffiths, Maggie Tabberer, Juliet N. Barker

Article2019

Risk prediction model for serious infections in psoriasis

Zenas Z N Yiu, Christina Sorbe, Mark Lunt, Stephan Jeff Rustenbach, L Kühl, Matthias Augustin, K.J. Mason, Darren M. Ashcroft, Christopher Em Griffiths, Richard B. Warren

Article2019

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study

Watcharee Rungapiromnan, K.J. Mason, Mark Lunt, Kathleen McElhone, A. David Burden, Martin K. Rutter, Richard B. Warren, Christopher Em Griffiths, Darren M. Ashcroft